Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03117660 · ClinicalTrials.gov registry record · Phase 1
Effects of Retinoids on CYP2D6 Activity During Pregnancy
A Phase 1 study of CYP2D6 Polymorphism, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT03117660: Completed Phase 1 study of CYP2D6 Polymorphism, sponsored by University of Washington.
NCT03117660 is a Phase 1 study of CYP2D6 Polymorphism that has completed, run by University of Washington. The registered enrollment target is 82 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03117660, a Phase 1 study of CYP2D6 Polymorphism, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective drug interaction study during pregnancy.
Primary Outcome
dextromethorphan metabolic ratio change from baseline during pregnancy
Conditions Studied
Interventions
- DRUG Vitamin A
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2017-07-25 |
| Est. Completion | 2022-10-31 |
| Phase | Phase 1 |
What the finished NCT03117660 record still lists
NCT03117660 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (37% higher).
The record links to 1 condition, with CYP2D6 Polymorphism appearing as the primary indexed condition, and to 1 intervention - of which Vitamin A is the first listed.
NCT03117660 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03117660 about?
NCT03117660 is a clinical study titled "Effects of Retinoids on CYP2D6 Activity During Pregnancy". Prospective drug interaction study during pregnancy.
What is the current status of trial NCT03117660?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 82 participants. The study started on 2017-07-25. Estimated completion is 2022-10-31.
What conditions does trial NCT03117660 study?
This clinical trial studies the following conditions: CYP2D6 Polymorphism.
What interventions are being tested in trial NCT03117660?
The interventions under investigation include: Vitamin A (DRUG).
Who is sponsoring clinical trial NCT03117660?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03117660 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for CYP2D6 Polymorphism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03117660's enrollment target sits among peer trials
82 669th of 2000 higher than 1,330 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI